Li YQ #, He MJ #, Wang ZY #, Duan ZY, Guo ZW, Wang ZT, Gong RJ, Chu TH, Cai JB*, Gao B*. The activation of STING signaling inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis. Cellular & Molecular Immunology. 2022 Jan;19(1):92-107
Shu W, Guo Z, Li L, Xiong Z, Wang Z, Yang Y, Li Y, He M, Gong R, Gao B*. Regulation of molecular chaperone GRP78 by HBV: control of viral replication and cell survival. Mol Cell Biol. 2020;40(3). pii: e00475-19
Wang ZY, Li YQ, Guo ZW, Zhou XH, Lu MD, Xue TC*, Gao B*. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication. Acta Pharmacol Sin. 2020;41(2):278-285
Yang Y, Zhao X, Wang Z, Shu W, Li L, Li Y, Guo Z, Gao B*, Xiong S*. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression. Hepatology. 2020; 4(71): 1154-1169
Li L #, Li Y #, Xiong Z, Shu W, Yang Y, Guo Z, Gao B*. FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α. Antiviral Res. 2019 Oct;170:104568
